OPG & BWXT to Produce Medical Isotope Mo-99 at Darlington Nuclear Station

摘要

Ontario Power Generation (OPG), its subsidiary Laurentis Energy Partners, BWXT ITG Canada Inc., and its affiliates (BWXT) are making significant progress toward the production of molybdenum-99 (Mo-99) at OPG's Darlington Nuclear Generating Station. BWXT has also built a fabrication facility at its current location in Peterborough, Ontario, to produce Mo-99 components that will be delivered by the specialized tooling, which will be installed at Darlington. The tooling will deliver the molybdenum into the Darlington reactor for irradiation, which will enable Darlington to become the first commercial operating nuclear reactor to produce Mo-99.